voxpoliticalonline.com
Brexit is bad for business as pharmaceutical firm expects to pay £70m because of it
New regulation processes, labs and approval systems for 1,700 GlaxoSmithKline products – necessitated by Brexit – will cost this single company up to £70 million, the firm’s presi…